Dr.V.Mohan
@drmohanv
Followers
129K
Following
31K
Media
5K
Statuses
16K
Chairman, Dr Mohan’s Diabetes Specialities Centre.Padma Shri Awardee, Dr B C Roy Awardee. Scientist with over 1800 publications. Author. Motivational speaker
Chennai, India
Joined March 2016
0
6
20
Early gestational diabetes now occurring in first trimester, South Asians at higher risk: Studies @NewIndianXpress @TheMornStandard @drmohanv @fogsiofficial @IntDiabetesFed @uniofwarwick @ICMRDELHI
@MoHFW_INDIA @JPNadda @OfficeofJPNadda
2
3
2
The coming years will split companies into two groups: those that become AI-native and those left catching up. The innovators who harness AI now will define the winners of tomorrow. Follow me for strategic insights on leading through the AI revolution.
6
12
118
@drmohanv @kamleshkhunti @EASDnews @ADA_DiabetesPro @AliRacaniere @IntDiabetesFed @rcgp @Rssdi_official @redGDPS Alternative view: as we diagnose & treat GDM, real-world estimates comparing GDM & obesity may underestimate risk from GDM. We treat GDM 'cos hyperglycaemia is a modifiable factor while obesity in pregnancy is not easily modifiable (have tried! -> DiGest). Both are important.
1
1
2
Up front & free to read in our Dec issue #editorspicks: Quantitative analysis of human adult pancreatic histology reveals separate fatty and fibrotic phenotypes in type 2 diabetes https://t.co/rvxu8MxfIZ
1
6
20
Greetings to Thiru Rajinikanth Ji on the special occasion of his 75th birthday. His performances have captivated generations and have earned extensive admiration. His body of work spans diverse roles and genres, consistently setting benchmarks. This year has been notable because
826
9K
69K
A look back and ahead at recent progress in GLP-1 medicines #weightloss #obesity from Timo Müller @HelmholtzMunich @TimoMueller_IDO
https://t.co/pl7LiWUy5t
nature.com
Nature Reviews Endocrinology - The efficacy of anti-obesity drugs that use glucagon-like peptide 1 receptor agonism and glucose-dependent insulinotropic polypeptide agonism raises critical...
0
18
57
NEW Continuous ketone monitoring for people with diabetes: international expert recommendations on a new technology #CKM may help reduce the risk of diabetic ketoacidosis. Read how this novel technology could improve outcomes for people at risk of #DKA: https://t.co/UIUHQT3xj9
0
27
75
You may not know it's there, but Fusarium ear rot can hit your yield & crop quality hard. 🌽 Hear tips from Tyler Harp on how to protect your corn with Miravis Neo.
2
8
23
Sarcopenic obesity and risk of cardio-cerebrovascular disease and mortality. https://t.co/Hyg2n0exSJ
0
13
70
Powe et al identify that higher placental expression of GKN1 is associated with diminished beta cell function in pregnancy and GDM https://t.co/xrL9CEEfRF
@CEPoweMD
1
4
8
Congratulations to Dr. Sanghamitra Pati, Additional Director General, @ICMRDELHI , on being conferred the prestigious FNASc honour. A proud moment celebrating excellence in scientific research.
9
20
105
Meet Razer AIKit: Your open-source launchpad for AI development. Fine-tune and run 280,000+ LLMs locally, scale across GPU clusters, and keep your data private — Available now on GitHub ⚡. Start local. Go cluster.
4
5
24
🌈 Obesity + Pregnancy = Elevated Risk A meta-analysis of 19 studies shows: 🚨 Obesity alone sharply raises risks of C-section, pre-eclampsia & induction of labour. 🚨 GDM alone increases risk too — but less than obesity. 🔥 Obesity + GDM together? A risk multiplier: ✨
1
7
27
Last week’s #DiaTechDemoDay brought a powerful showcase of student-driven innovation tackling real diabetes-care challenges in rural Georgia. Students from @kennesawstate and @GeorgiaTech shared tech-forward solutions driven by collaboration to improve health outcomes.
0
3
4
1
2
36
Diabetes doesn’t just affect blood sugar — it also silently damages your liver. High blood sugar and insulin resistance can lead to fat accumulation in the liver (NAFLD), inflammation (NASH), scarring (fibrosis), and even increase the risk of liver cancer. This “hidden” harm
0
0
10
📣 PostgreSQL developers: Meet Azure HorizonDB the new AI-ready database service with native AI capabilities built in. For enterprise scale, security, and performance without compromise.
1
5
42
NEW: "Staging prediabetes and type 2 diabetes: the time to start is now" Viral N Shah and colleagues propose a model for type 2 diabetes that assumes gradual decline in β-cell function or mass over time in people at risk for developing type 2 diabetes. https://t.co/hKTVw4n3kE
0
57
148
New post: The unsung heroes of GLP-1 agonist therapies. How Padmanabhan Balaram and Isabella Karle laid the basic structural foundations for today's revolutionary drugs
1
22
69
SSSIHL and Motherson Techno Tools Ltd (MTTL) have entered into a significant collaboration to promote joint research, technological innovation, and industry-academia engagement. For more: https://t.co/mlkrNmGi7X
0
1
11
Tributes to Mahakavi Subramania Bharati on his birth anniversary. His verses ignited courage and his thoughts had the power to leave a lasting impression on the minds of countless people. He illuminated India’s cultural and national consciousness. He worked towards creating a
571
4K
24K
You thought you were just buying a phone. Turns out, you're shaping the future. Big Tech companies are giving money to radically overhaul the U.S. justice system. Unplugged is a different kind of smartphone from a company that believes in a strong, thriving America.
0
8
33
ADA Standard of Care in Diabetes 2026 “What’s New” from ADA Standards of Care 2026 (focusing on clinically important changes): 1. Big picture shifts Person-first, inclusive language reinforced across all sections. Multiple cross-specialty endorsements strengthened (ACC, AGS,
1
26
75